AdvisorShares Psychedelics Beta vs. Equity Positions Weight
| PSIL Etf | USD 12.04 0.25 2.03% |
For AdvisorShares Psychedelics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AdvisorShares Psychedelics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AdvisorShares Psychedelics ETF utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AdvisorShares Psychedelics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AdvisorShares Psychedelics ETF over time as well as its relative position and ranking within its peers.
AdvisorShares |
The market value of AdvisorShares Psychedelics is measured differently than its book value, which is the value of AdvisorShares that is recorded on the company's balance sheet. Investors also form their own opinion of AdvisorShares Psychedelics' value that differs from its market value or its book value, called intrinsic value, which is AdvisorShares Psychedelics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AdvisorShares Psychedelics' market value can be influenced by many factors that don't directly affect AdvisorShares Psychedelics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AdvisorShares Psychedelics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AdvisorShares Psychedelics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AdvisorShares Psychedelics Equity Positions Weight vs. Beta Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AdvisorShares Psychedelics's current stock value. Our valuation model uses many indicators to compare AdvisorShares Psychedelics value to that of its competitors to determine the firm's financial worth. AdvisorShares Psychedelics ETF is rated number one ETF in beta as compared to similar ETFs. It also is rated number one ETF in equity positions weight as compared to similar ETFs making about 133.22 of Equity Positions Weight per Beta. Comparative valuation analysis is a catch-all technique that is used if you cannot value AdvisorShares Psychedelics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.AdvisorShares Equity Positions Weight vs. Beta
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
AdvisorShares Psychedelics |
| = | 0.69 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
AdvisorShares Psychedelics |
| = | 91.92 % |
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
AdvisorShares Equity Positions Weight Comparison
AdvisorShares Psychedelics is currently under evaluation in equity positions weight as compared to similar ETFs.
Beta Analysis
As returns on the market increase, AdvisorShares Psychedelics' returns are expected to increase less than the market. However, during the bear market, the loss of holding AdvisorShares Psychedelics is expected to be smaller as well.
AdvisorShares Psychedelics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AdvisorShares Psychedelics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AdvisorShares Psychedelics will eventually generate negative long term returns. The profitability progress is the general direction of AdvisorShares Psychedelics' change in net profit over the period of time. It can combine multiple indicators of AdvisorShares Psychedelics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. Advisorshares Psychedelics is traded on NYSEARCA Exchange in the United States.
AdvisorShares Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AdvisorShares Psychedelics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AdvisorShares Psychedelics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AdvisorShares Psychedelics' important profitability drivers and their relationship over time.
Use AdvisorShares Psychedelics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AdvisorShares Psychedelics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AdvisorShares Psychedelics will appreciate offsetting losses from the drop in the long position's value.AdvisorShares Psychedelics Pair Trading
AdvisorShares Psychedelics ETF Pair Trading Analysis
The ability to find closely correlated positions to AdvisorShares Psychedelics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AdvisorShares Psychedelics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AdvisorShares Psychedelics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AdvisorShares Psychedelics ETF to buy it.
The correlation of AdvisorShares Psychedelics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AdvisorShares Psychedelics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AdvisorShares Psychedelics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AdvisorShares Psychedelics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your AdvisorShares Psychedelics position
In addition to having AdvisorShares Psychedelics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
To fully project AdvisorShares Psychedelics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AdvisorShares Psychedelics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AdvisorShares Psychedelics' income statement, its balance sheet, and the statement of cash flows.